Twenty Years of Saving and Improving Lives
In 2012, PPTA celebrated its 20th Anniversary. In two short decades, it has become recognized as a global leader and authoritative voice of the plasma protein therapeutics industry.
PPTA represents the private sector manufacturers of plasma-derived and recombinant analog therapies, collectively known as plasma protein therapies and the collectors of source plasma.
The Associations originally formed as the International Plasma Products Industry Association (IPPIA) in 1992. The organization started a European division in 1994, the European Association of the Plasma Products Industry (EAPPI) and in 1998 formed IPPIA in North America. In 2000, EAPPI and IPPIA merged to form the Plasma Protein Therapeutics Association (PPTA). In 2002, PPTA merged with the American Blood Resources Association (ABRA) and added the Source Division to represent collectors.
PPTA’s accomplishments demonstrate continued leadership and innovation. The Association’s dedication to quality, safety and standards has resulted in no reported viral transmissions for two decades. In addition, the Association has established constructive dialog and relationships with regulators, policymakers and patient organizations throughout the world and in doing so, has become a trusted and reliable leader in combatting rare diseases. Finally, PPTA has maintained an unwavering commitment to advocacy efforts that supports patient access to care.
1992-Originally formed as the International Plasma Products Industry Association (IPPIA)
1994—European Association of the Plasma Products Industry formed (EAPPI)
1998—IPPIA, North America Division formed
2000—EAPPI and IPPIA merge to form PPTA
2002—PPTA merges with the American Blood Resources Association (ABRA)
2002—PPTA Source Division formed to represent plasma collectors
Click images to enlarge.
The Hilfenhaus Award conferred to Prof. Farkas at the IPPC 2017 +
The 2017 Hilfenhaus Award was bestowed to Professor Henriette Farkas, MD, Ph.D., DSc, during IPPC 2017 for her work related to treating those suffering from Hereditary Angioedema (HAE) and working to improve treatments and patients’ quality of life. She is professor of allergology and clinical immunology at the Hungarian Angioedema Center at Semmelweis University in Budapest, Hungary.Read More
Highlights from IPPC 2017 +
Mr. Bruno Santoni, Executive Director, PPTA Europe, opened the well-attended IPPC 2017 welcoming the more than 300 attendees to Prague. PPTA thanks its sponsors who help make the IPPC possible. Download the IPPC app for a complete list of sessions and many of the presentations.Read More
PPTA Remembers John W. Walsh +